Dawn Raids Are Back: What Sanofi’s Case Teaches Us About Compliance Readiness

The European Commission has raided Sanofi’s offices in France and Germany over suspected anticompetitive practices in the flu vaccine market. Beyond the headlines, the case is a reminder that dawn raids don’t just target classic cartels or price-fixing. This time, the suspicion is anticompetitive disparagement—a risk that often goes unnoticed by compliance officers. The lesson? A strong dawn raid protocol, regular training, and a comprehensive competition risk map are essential. Because when regulators come knocking, it’s not just about prices—it’s about being ready for the unexpected.